November 28, 2025 - 16:25

Gene Woods, the CEO of Atrium Health’s parent company, has seen his total compensation rise dramatically, reaching an impressive $25.8 million. This 49% increase positions him well ahead of other major health-system executives in North Carolina, highlighting the growing financial rewards for leadership in the healthcare sector.
Woods' substantial pay package includes a mix of salary, bonuses, and stock options, reflecting both his performance and the company's growth trajectory. Atrium Health has been expanding its services and facilities, contributing to its status as one of the leading healthcare providers in the region.
The significant hike in Woods' salary has sparked discussions about executive compensation in the healthcare industry, particularly in light of ongoing challenges such as rising operational costs and the need for improved patient care. As healthcare organizations navigate these complexities, the disparity in pay between top executives and frontline workers continues to be a topic of concern among stakeholders.
February 26, 2026 - 20:16
Mom says son had mental health issues before Walnut Creek police fatally shot himA grieving mother is publicly stating that her son was experiencing significant mental health issues prior to being fatally shot by a Walnut Creek police officer early Thursday morning. The...
February 26, 2026 - 01:23
Rainier Beach High School confirms active tuberculosis case, 130 people possibly exposedPublic health officials have confirmed an active case of tuberculosis at Rainier Beach High School in Seattle. The investigation is now focused on identifying and evaluating individuals who may...
February 25, 2026 - 02:30
**Embracing a Slower Pace: A Weekly Ritual for Personal and Planetary Health**In our fast-paced world, the concept of intentionally slowing down for one day each week is gaining recognition not just as a lifestyle choice, but as a powerful tool for improving well-being and...
February 24, 2026 - 17:24
In earnings call, Hims CEO addresses scrutiny of GLP-1 compoundingDuring a recent quarterly earnings discussion, the CEO of Hims & Hers, Andrew Dudum, directly confronted the growing regulatory and media attention surrounding compounded versions of popular GLP-1...